Innovation in Computer Related | Innoget

Innovation in Computer Related | Innoget

Unitat de Valorització de la URV posted this:
Licensing Manager at Fundació URV

Method for quantification of the speed of printing of continuous fibers in processes of near-field electrospinning and electrohydrodynamic jet printing for microfabrication The offered invention allows controlling the process of electrohydrodynamic (EHD) jet printing in which an ink is printed on a substrate as a continuous line or fiber, forming predesigned 2D patterns and 3D structures. This is also known as near-field electrospinning (NFES). The offered technology allows determining the speed at which the EHD ink jet approaches the substrate before it collects transforming into a printed fiber. The knowledge of its speed of approach is critical for controlling the process of printing and create high-resolution patterns and structures, and, ultimately, for ensuring the desired performance of the printed fibers (device). In this invention, the jet trajectory is oscillated electrostatically at a known frequency, resulting in a repeating printed pattern. The speed is obtained from macroscopic, easily quantifiable features of the printed pattern, such as width on a serpentine track (2D pattern), or diameter of a cylinder (3D structure). A patent is pending for this technology.

Method for quantification of the speed of printing of continuous fibers in processes of near-field electrospinning and electrohydrodynamic jet printing for microfabrication

Unitat de Valorització de la URV posted this:
Licensing Manager at Fundació URV

3D printing of continuous fibers for microfabrication, such as flexible electronics and biofabrication A versatile 3D printing technology is offered in which electrostatic control is used to form a continuous electrohydrodynamic ink jet and to precisely position it on a substrate forming a predefined pattern made of solid fiber with fiber diameter typically in the few-micron or submicron ranges. The technology uses electrostatic forces to deflect the trajectory of the fast-moving jet in its flight toward the substrate, in a time-varying fashion. This technology is capable of printing predefined 2D patterns and 3D microstructures with submicrometer resolution and unprecedented speed of up to 2000 fiber layers per second, resulting in total printing time of up to about 1 second per 3D structure. A patent is pending for this technology.

3D printing of continuous fibers for microfabrication, such as flexible electronics and biofabrication

Yissum - Research Development Company of the Hebrew University posted this:

Naturally Occurring Compounds for Treating Pathogenic Factors Common to Cystic Fibrosis Cannabis project Derivatives of cannabinoids have an antimicrobial and anti biofilm effect on pseudomonas and candida which are major ethological pathogenic factors in CF Project ID : 6-2019-6720

Yissum - Research Development Company of the Hebrew University posted this:

Identifying and Optimizing Treatment for Neuropathic Pain Identifying and Optimizing Treatment for Neuropathic Pain Project ID : 6-2019-9749

Identifying and Optimizing Treatment for Neuropathic Pain

Yissum - Research Development Company of the Hebrew University posted this:

High Speed, High Spatial Resolution Scanning Micro-ellipsometer Metrology instrument for measuring coatings properties/dimensions Keywords: measurement, device, Project ID : 14-2017-4398

High Speed, High Spatial Resolution Scanning Micro-ellipsometer

Ukrainian Laboratories posted this:

Computer aided drug discovery services Otava Research Institute helps researchers around the world develop advanced solutions for the variety of research projects maximizing their efficiencies, and, most of all, respecting their budgets. Our experts are involved in the development of leading compounds at any stage of the R&D process: starting from target identification to lead optimization

Computer aided drug discovery services

Ivan Rodriguez Rosello posted this:
Licensing Manager at Universidad de Alicante

New multifunctional material for controlled-drug-release implants The "Advanced Materials" research group at the University of Alicante has developed a foamed material comprising three phases: a structural matrix, at least one host phase, and a fluid. This material is characterized by the fact that the structural matrix comprises a plurality of interconnected porous cavities, the host phase(s) is/are housed within at least one porous cavity of the structural matrix and the fluid is housed within the porous cavities. The host phase(s) can be housed within the porous cavities of the structural matrix without maintaining any union or maintaining discrete unions with the latter. The structural matrix may consist of a material of a metallic, polymeric, ceramic nature or mixtures thereof. Meanwhile, the host phase(s) is/are a functional material, the fluid being a liquid or a gas. These materials have many potential uses, among which ones is as an implant material, with the additional possibility of exerting a controlled release of drugs. Companies interested in commercial exploitation of this material through a patent license agreement are sought.

New multifunctional material for controlled-drug-release implants

Montserrat Sole Castellvi posted this:
Project Manager at Knowledge Innovation Market

Minimally invasive system for faster, simpler and cheaper detection of breast cancer metastasis HYPOSENS technology is a unique all optical cancer prognostic system that determines specifically the presence of cancer cells in the breast lymph nodes, which indicates cancer metastasis and thus a bad prognosis. This tool will be extremely useful for patient stratification and will represent a significant decrease in the diagnostic costs and an increase in the welfare of patients. We are looking for collaborators/funding to further validate the technology at clinical level.

Minimally invasive system for faster, simpler and cheaper detection of breast cancer metastasis

Servei de Gestió de la Innovació posted this:
Licensing Manager at Universitat Politècnica de Catalunya - UPC

Hybrid diffractive/refractive optics simulator: method and device The invention relates to a system and to a method for characterizing, designing and/or modifying optical properties of hybrid diffractive/refractive lenses with no need of manufacturing such a lens.

Consejo Superior de Investigaciones Científicas posted this:

Biotechnological production of 11α hydroxylated steroids using recombinant bacteria.CSIC has developed a procedure for the biotechnological production of 11α hydroxylated steroids by generating and subsequent use of recombinant bacteria. These recombinant bacteria allow to perform microbial biotransformation processes that result in 11αhydroxylated steroid compounds from raw materials such as phytosterols and intermediate products efficiently and economically. These compounds have numerous applications in pharmacology. Companies are sought for implementing and commercializing the new technology under patent license agreement. An offer for Patent Licensing

Biotechnological production of 11α hydroxylated steroids using recombinant bacteria.

Consejo Superior de Investigaciones Científicas posted this:

Fabrication of tips for scanning probe microscopy with enhanced resolution CSIC has developed tips for scanning probe microscopy (SPM) where an isolated nanoparticle is placed at the apex of the tip. The method allows to tailor the shape, size and composition of the nanoparticle improving the measuring capabilities of the tips. These novel tips are suitable for techniques that combine imaging, such as SPM and spectroscopy like tip-enhanced Raman spectroscopy (TERS). Industrial partners manufacturers of laboratory equipment are being sought to collaborate through a patent license agreement. An offer for Patent Licensing

Fabrication of tips for scanning probe microscopy with enhanced resolution

Consejo Superior de Investigaciones Científicas posted this:

Peptide for cancer control linked to IL13R R R α α 2 2 o o v v e e r r e e x x p p r r e e s s s s i i o o n n CSIC has developed a peptide capable of inhibiting the signaling of IL-13 mediated by IL13Rα2. This peptide alone or within a nanoparticle or virus-like particles can be used in a pharmaceutical composition for the treatment of pathologies in which IL13Rα2 is overexpressed. This composition would be useful in the treatment and control of metastasis of colon cancer and other tumors (i.e glioblastoma), as well as in other pathologies such as asthma, atopic dermatitis or fibrosis. Industrial partners are being sought to develop and commercialized the products through a patent licence agreement. An offer for Patent Licensing

Peptide for cancer control linked to IL13R

Consejo Superior de Investigaciones Científicas posted this:

Piperidine derivatives for the control of Parkinson's and Alzheimer's CSIC has synthesized a series of piperidine derivatives that are capable of inhibiting the activity of the enzyme phosphodiesterase-8 (PDE8). This inhibitory activity makes them useful for the treatment of neurodegenerative diseases in which this enzyme is overexpressed. The compounds developed are, therefore, a new therapeutic alternative for Alzheimer's disease, and Parkinson, among others. Industrial partners from pharmaceutical industry are being sought to develop and commercialized the compounds through a patent licence agreement. An offer for Patent Licensing

Piperidine derivatives for the control of Parkinson's and Alzheimer's

Consejo Superior de Investigaciones Científicas posted this:

Regulatory compounds of synaptic transmission for the treatment of neurological diseases The CSIC and IRYCIS (Ramón y Cajal Institute for Health Research) have developed a group of compounds. These compounds have the ability to regulate the number of synapses that are formed between neurons, as well as the probability that neurotransmitters are released from these, because they have the capability of modulate the interactions that take place between the regulatory proteins NCS-1 and Ric8a that regulate these two independent processes. Due to these neuromodulatory properties, these compounds are useful for the treatment of neurological diseases as Alzheimer's disease, Huntington or Parkinson's diseases among others. Industrial partners from the ophthalmic or pharmaceutical industry are being sought to collaborate through a patent license agreement. An offer for Patent Licensing

Regulatory compounds of synaptic transmission for the treatment of neurological diseases

Consejo Superior de Investigaciones Científicas posted this:

Antibiotics to treat diseases caused by Helicobacter CSIC, the University of Zaragoza, Institute Pasteur, IISA and ARAID have developed chemical derivatives that act selectively against the bacterium Helicobacter pylori, managing to reduce the bacterial load and even eradicate gastric infections caused by it. Industrial partners from the pharmaceutical industry are being sought to collaborate through a patent licence agreement. An offer for Patent Licensing

Antibiotics to treat diseases caused by Helicobacter

1
2
3
4
5